Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesWarby Parker Inc

Warby Parker Inc

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
25.475 USD -0.60 ( 2.32%)
Last update at 2026-11-06T21:02:00Z
VOLUME
5094842
Market Cap
3008.62M
P/E
405.67

Momentum Score

…

Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses. It also provides accessories, such as cases, pouches, lenses kit with anti-fog spray, travel cases, lenses cloth, anti-fog lens spray, and sun clip-ons through its stores, website, and mobile apps. In addition, the company offers eye exams and vision tests, as well as optical services. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
25.47
Low
27.42
High
52 Week Price Range
14.96
Low
31.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Warby Parker Inc sells prescription eyewear, sunglasses and related eye-care products through a vertically integrated direct-to-consumer model combining e-commerce and company-owned stores. Long-term growth may be driven by omnichannel store roll-out, recurring demand for vision products and expansion into contact lenses and in-store eye-care services, which could support revenue diversification and margin improvement.

Important risks include intense competition from incumbents and low-cost online players, execution and profitability pressure from store expansion, sensitivity to consumer spending and regulatory/licensing constraints for clinical services.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
26.08
Dividend Yield
-
Revenue TTM
911.61M
Revenue Per Share
7.39
Gross Profit TTM
484.23M
Debt / Equity
0.63
ROE
2.06%
Net Debt
-53.21M
ROCE
0.53%
Diluted EPS TTM
0.06

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 3.04M -19.52M -62.76M -109.90M -144.01M
Net income 1.64M -20.39M -63.20M -110.39M -144.27M
Selling general administrative 475.92M 344.25M 345.47M 452.26M 461.41M
Selling and marketing expenses - 95.80M 76.10M - -
Gross profit 470.58M 426.83M 365.22M 341.06M 317.75M
Reconciled depreciation 50.28M 45.87M 37.10M 31.86M 21.87M
Ebit 3.04M -19.52M -62.76M -111.20M -143.66M
Ebitda 53.32M 26.35M -24.21M -79.34M -121.79M
Depreciation and amortization 50.28M 45.87M 38.55M 31.86M 21.87M
Non operating income net other - - - - -0.35M
Operating income -5.34M -30.11M -72.00M -111.20M -143.66M
Other operating expenses 877.24M 801.43M 741.76M 709.32M 684.46M
Interest expense - - - -1.31M 0.35M
Tax provision 1.40M 0.88M 0.46M 0.50M 0.26M
Net interest income 8.38M 10.60M 8.20M 1.31M -0.35M
Income tax expense 1.40M 0.88M 0.43M 0.50M 0.26M
Total revenue 871.90M 771.32M 669.76M 598.11M 540.80M
Total operating expenses 475.92M 456.95M 437.22M 452.26M 461.41M
Cost of revenue 401.33M 344.48M 304.54M 257.05M 223.05M
Total other income expense net 8.38M 10.60M 9.23M 1.31M -0.35M
Net income from continuing ops 1.64M -20.39M -64.40M -110.39M -144.27M
Net income applicable to common shares - - - -110.39M -157.41M
Preferred stock and other adjustments - - - - 13.14M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 720.92M 676.49M 580.31M 568.71M 440.65M
Intangible assets - - 12.30M - -
Other current assets 18.28M 17.59M 17.71M 15.70M 13.48M
Total liab 353.19M 336.42M 278.52M 282.06M 154.65M
Total stockholder equity 367.73M 340.07M 301.79M 286.65M 286.00M
Deferred long term liab - - - 8.20M 36.54M
Other current liab 52.88M 54.24M 48.73M 60.59M 4.30M
Common stock 0.01M 0.01M 0.01M 0.01M 0.01M
Capital stock 0.01M 0.01M 0.01M 0.01M 0.01M
Retained earnings -685.58M -687.22M -666.83M -603.63M -493.24M
Other liab - - - 1.67M 36.54M
Other assets - - - 8.50M 0.47M
Cash 286.36M 254.16M 216.89M 208.59M 256.42M
Total current liabilities 150.13M 130.35M 127.09M 129.56M 118.10M
Current deferred revenue 33.87M 32.36M 31.62M 25.63M 22.07M
Net debt -53.21M -28.81M -42.44M -35.21M -256.42M
Short term debt 31.40M 20.23M 24.29M 22.55M 60.84M
Short long term debt total 233.15M 225.35M 174.46M 173.38M -
Other stockholder equity 1054.78M 1029.22M 970.13M 890.91M 338.57M
Property plant equipment - - - 254.34M 112.19M
Total current assets 352.44M 326.05M 298.62M 294.57M 327.98M
Net tangible assets - - - 275.35M 286.00M
Net receivables 3.29M 1.95M 1.78M 1.44M 0.99M
Inventory 44.51M 52.34M 62.23M 68.85M 57.09M
Accounts payable 31.98M 23.52M 22.46M 20.79M 30.89M
Accumulated other comprehensive income -1.48M -1.94M -1.53M -0.65M 0.02M
Common stock total equity - - - - 0.01M
Retained earnings total equity - - - - -493.24M
Non currrent assets other 10.23M 6.70M 7.06M 8.50M 0.47M
Non current assets total 368.48M 350.44M 281.69M 274.14M 112.67M
Capital lease obligations 233.15M 225.35M 174.46M 173.38M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -66.03M -55.31M -60.18M -48.51M
Change to liabilities - - - -4.36M -2.66M
Total cashflows from investing activities -67.05M -66.03M -54.67M -60.18M -48.51M
Net borrowings - - 0.00M 0.09M 31.61M
Total cash from financing activities -12.00M 4.96M 2.87M 3.29M 23.00M
Change to operating activities - - - 2.06M 10.11M
Net income 1.64M -20.39M -63.20M -110.39M -144.27M
Change in cash 32.20M 37.27M 8.31M -47.83M -57.67M
Begin period cash flow 254.16M 216.89M 208.59M 256.42M 314.08M
End period cash flow 286.36M 254.16M 216.89M 208.59M 256.42M
Total cash from operating activities 110.78M 98.74M 60.99M 10.37M -31.99M
Issuance of capital stock - - 2.11M 2.74M 0.00M
Depreciation 50.28M 45.87M 38.55M 31.86M 21.87M
Other cashflows from investing activities - -2.00M -1.00M - -
Change to inventory 7.83M 9.89M 6.61M -11.79M -18.62M
Change to account receivables -1.34M -0.17M -0.34M -0.45M -0.39M
Sale purchase of stock - - 0.00M 0.00M -8.09M
Other cashflows from financing activities -14.36M 0.33M 2.87M 0.55M 31.08M
Change to netincome - - - 103.45M 114.91M
Capital expenditures 67.05M 64.03M 53.67M 60.18M 48.51M
Change receivables - - - - -0.39M
Cash flows other operating - - - - -2.82M
Cash and cash equivalents changes - - - - -57.51M
Change in working capital 17.55M 19.26M 5.81M -14.55M -24.50M
Stock based compensation 34.54M 47.29M 70.51M 98.03M 107.15M
Other non cash items 6.78M 6.72M 9.32M 5.42M 7.76M
Free cash flow 43.74M 34.71M 7.32M -49.81M -80.51M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
WRBY
Warby Parker Inc		 -0.60
2.32%		 25.48 405.67 59.88 3.30 8.11 3.44 57.00
ISRG
Intuitive Surgical Inc		 -15.72
3.36%		 452.80 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme		 2.75
1.29%		 215.85 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 0.92
0.86%		 107.77 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 -1.69
0.79%		 211.86 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

Warby Parker Inc

Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses. It also provides accessories, such as cases, pouches, lenses kit with anti-fog spray, travel cases, lenses cloth, anti-fog lens spray, and sun clip-ons through its stores, website, and mobile apps. In addition, the company offers eye exams and vision tests, as well as optical services. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

233 Spring Street, New York, NY, United States, 10013

646 847 7215

https://www.warbyparker.com

2275

Name Title Year Born
Mr. Neil Harris Blumenthal Co-Founder, Pres, Co-CEO & Co-Chair 1981
Mr. David Abraham Gilboa Co-Founder, Co-CEO & Co-Chair 1982
Mr. Andrew M. Hunt Co-Founder & Independent Director NA
Mr. Jeff Raider Co-Founder & Independent Director NA
Mr. Steve Miller Sr. VP & CFO NA
Ms. Stephanie Pullings Hart Sr. VP of Operations 1974
Mr. Jeffrey Saunders Sr. VP & CTO NA
Ms. Tina Romani VP of Investor Relations NA
Ms. Lori Krauss Sr. VP & Chief Marketing Officer NA
Ms. Chelsea Kaden Sr. VP & Head of People NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…